▶ 調査レポート

世界の四価インフルエンザワクチン産業調査2019-2025
• 英文タイトル：Global Quadrivalent Flu Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の四価インフルエンザワクチン産業調査2019-2025 / Global Quadrivalent Flu Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / QYR9NV16878資料のイメージです。• レポートコード：QYR9NV16878
• 出版社/出版日：QYResearch / 2019年11月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、117ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・ヘルスケア
• 販売価格（消費税別）
  Single User￥735,000 (USD4,900)▷ お問い合わせ
  Enterprise License￥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
※本調査レポートでは、世界の四価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。四価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、診療所、公衆衛生局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・四価インフルエンザワクチンの種類別市場規模：筋肉内注射、点鼻薬、皮内注射
・四価インフルエンザワクチンの用途別市場規模：病院、診療所、公衆衛生局、その他
・四価インフルエンザワクチンの地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール：Sanofi Pasteur、AstraZeneca、CSL、Abbott、GlaxoSmithKline
・市場規模予測2019-2025：生産量
・市場規模予測2019-2025：消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

In 2018, the global Quadrivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Quadrivalent Flu Vaccine.
This study researches the market size of Quadrivalent Flu Vaccine, presents the global Quadrivalent Flu Vaccine sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Quadrivalent Flu Vaccine in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Quadrivalent Flu Vaccine for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
AstraZeneca
CSL
Abbott
GlaxoSmithKline
…

Market Segment by Product Type
Intramuscular Injection
Nasal Spray
Intradermal Shot

Market Segment by Application
Hospital
Clinic
Public Health Agency
Other

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Quadrivalent Flu Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Quadrivalent Flu Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Quadrivalent Flu Vaccine are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type
1.3.2 Intramuscular Injection
1.3.3 Nasal Spray
1.3.4 Intradermal Shot
1.4 Market Segment by Application
1.4.1 Global Quadrivalent Flu Vaccine Market Share by Application (2019-2025)
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Public Health Agency
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Quadrivalent Flu Vaccine Market Size
2.1.1 Global Quadrivalent Flu Vaccine Revenue 2014-2025
2.1.2 Global Quadrivalent Flu Vaccine Sales 2014-2025
2.2 Quadrivalent Flu Vaccine Growth Rate by Regions
2.2.1 Global Quadrivalent Flu Vaccine Sales by Regions 2014-2019
2.2.2 Global Quadrivalent Flu Vaccine Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Quadrivalent Flu Vaccine Sales by Manufacturers
3.1.1 Quadrivalent Flu Vaccine Sales by Manufacturers 2014-2019
3.1.2 Quadrivalent Flu Vaccine Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Quadrivalent Flu Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Quadrivalent Flu Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Quadrivalent Flu Vaccine Price by Manufacturers
3.4 Key Manufacturers Quadrivalent Flu Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Quadrivalent Flu Vaccine Market
3.6 Key Manufacturers Quadrivalent Flu Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Intramuscular Injection Sales and Revenue (2014-2019)
4.1.2 Nasal Spray Sales and Revenue (2014-2019)
4.1.3 Intradermal Shot Sales and Revenue (2014-2019)
4.2 Global Quadrivalent Flu Vaccine Sales Market Share by Type
4.3 Global Quadrivalent Flu Vaccine Revenue Market Share by Type
4.4 Quadrivalent Flu Vaccine Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Quadrivalent Flu Vaccine Sales by Application

6 North America
6.1 North America Quadrivalent Flu Vaccine Breakdown Data by Company
6.2 North America Quadrivalent Flu Vaccine Breakdown Data by Type
6.3 North America Quadrivalent Flu Vaccine Breakdown Data by Application
6.4 North America Quadrivalent Flu Vaccine Breakdown Data by Countries
6.4.1 North America Quadrivalent Flu Vaccine Sales by Countries
6.4.2 North America Quadrivalent Flu Vaccine Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Quadrivalent Flu Vaccine Breakdown Data by Company
7.2 Europe Quadrivalent Flu Vaccine Breakdown Data by Type
7.3 Europe Quadrivalent Flu Vaccine Breakdown Data by Application
7.4 Europe Quadrivalent Flu Vaccine Breakdown Data by Countries
7.4.1 Europe Quadrivalent Flu Vaccine Sales by Countries
7.4.2 Europe Quadrivalent Flu Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Quadrivalent Flu Vaccine Breakdown Data by Company
8.2 Asia Pacific Quadrivalent Flu Vaccine Breakdown Data by Type
8.3 Asia Pacific Quadrivalent Flu Vaccine Breakdown Data by Application
8.4 Asia Pacific Quadrivalent Flu Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific Quadrivalent Flu Vaccine Sales by Countries
8.4.2 Asia Pacific Quadrivalent Flu Vaccine Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Quadrivalent Flu Vaccine Breakdown Data by Company
9.2 Central & South America Quadrivalent Flu Vaccine Breakdown Data by Type
9.3 Central & South America Quadrivalent Flu Vaccine Breakdown Data by Application
9.4 Central & South America Quadrivalent Flu Vaccine Breakdown Data by Countries
9.4.1 Central & South America Quadrivalent Flu Vaccine Sales by Countries
9.4.2 Central & South America Quadrivalent Flu Vaccine Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Quadrivalent Flu Vaccine Breakdown Data by Type
10.2 Middle East and Africa Quadrivalent Flu Vaccine Breakdown Data by Application
10.3 Middle East and Africa Quadrivalent Flu Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Countries
10.3.2 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Quadrivalent Flu Vaccine
11.1.4 Quadrivalent Flu Vaccine Product Introduction
11.1.5 Sanofi Pasteur Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Quadrivalent Flu Vaccine
11.2.4 Quadrivalent Flu Vaccine Product Introduction
11.2.5 AstraZeneca Recent Development
11.3 CSL
11.3.1 CSL Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Quadrivalent Flu Vaccine
11.3.4 Quadrivalent Flu Vaccine Product Introduction
11.3.5 CSL Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Quadrivalent Flu Vaccine
11.4.4 Quadrivalent Flu Vaccine Product Introduction
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Quadrivalent Flu Vaccine
11.5.4 Quadrivalent Flu Vaccine Product Introduction
11.5.5 GlaxoSmithKline Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Quadrivalent Flu Vaccine Sales Channels
12.2.2 Quadrivalent Flu Vaccine Distributors
12.3 Quadrivalent Flu Vaccine Customers

13 Market Forecast
13.1 Global Quadrivalent Flu Vaccine Sales and Revenue Forecast 2019-2025
13.2 Global Quadrivalent Flu Vaccine Sales Forecast by Type
13.3 Global Quadrivalent Flu Vaccine Sales Forecast by Application
13.4 Quadrivalent Flu Vaccine Forecast by Regions
13.4.1 Global Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025
13.4.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Quadrivalent Flu Vaccine Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Quadrivalent Flu Vaccine Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Quadrivalent Flu Vaccine Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Quadrivalent Flu Vaccine Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Quadrivalent Flu Vaccine Product Picture
Table Quadrivalent Flu Vaccine Key Market Segments
Table Major Manufacturers Quadrivalent Flu Vaccine Covered in This Report
Table Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$)
Figure Global Quadrivalent Flu Vaccine Sales Market Shar by Type 2014-2025
Figure Intramuscular Injection Figures
Table Major Manufacturers of Intramuscular Injection
Figure Nasal Spray Figures
Table Major Manufacturers of Nasal Spray
Figure Intradermal Shot Figures
Table Major Manufacturers of Intradermal Shot
Table Global Quadrivalent Flu Vaccine Market Share by Application 2019-2025 (K Doses)
Figure Hospital Use Case
Figure Clinic Use Case
Figure Public Health Agency Use Case
Figure Other Use Case
Figure Quadrivalent Flu Vaccine Report Years Considered
Figure Global Quadrivalent Flu Vaccine Market Size 2014-2025 (Million US$)
Figure Global Quadrivalent Flu Vaccine Sales 2014-2019 (K Doses)
Table Global Quadrivalent Flu Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Quadrivalent Flu Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Quadrivalent Flu Vaccine Sales Market Share by Regions 2014-2019
Figure Global Quadrivalent Flu Vaccine Sales Market Share by Regions 2014-2019
Figure Global Quadrivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Global Quadrivalent Flu Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Quadrivalent Flu Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Quadrivalent Flu Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Quadrivalent Flu Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Quadrivalent Flu Vaccine Sales Share by Manufacturers in 2018
Table Quadrivalent Flu Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Quadrivalent Flu Vaccine Value Share by Manufacturers in 2018
Table Global Quadrivalent Flu Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Quadrivalent Flu Vaccine Price (2014-2019) (USD/Dose)
Table Key Manufacturers Quadrivalent Flu Vaccine Plants/Factories Distribution
Table Key Manufacturers Quadrivalent Flu Vaccine Area Served
Table Date of Key Manufacturers Enter into Quadrivalent Flu Vaccine Market
Table Key Manufacturers Quadrivalent Flu Vaccine Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Intramuscular Injection Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Nasal Spray Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Intradermal Shot Sales an目录输出!D Revenue (2014-2019) (K Doses) & (Million US$)
Table Global Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Global Quadrivalent Flu Vaccine Sales Share by Type (2014-2019)
Figure Global Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2018
Table Global Quadrivalent Flu Vaccine Revenue by Type (2014-2019) (Million US$)
Table Global Quadrivalent Flu Vaccine Revenue Share by Type (2014-2019)
Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2014-2019)
Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Type in 2018
Table Quadrivalent Flu Vaccine Price by Type 2014-2019 (USD/Dose)
Table Global Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Global Quadrivalent Flu Vaccine Sales Share by Application (2014-2019)
Figure Global Sales Quadrivalent Flu Vaccine Market Share by Application (2014-2019)
Figure Global Sales Quadrivalent Flu Vaccine Market Share by Application in 2018
Figure North America Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Quadrivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table North America Quadrivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure North America Quadrivalent Flu Vaccine Sales Market Share by Company in 2018
Table North America Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table North America Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure North America Quadrivalent Flu Vaccine Market Share by Type in 2018
Table North America Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table North America Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure North America Quadrivalent Flu Vaccine Market Share by Application in 2018
Table North America Quadrivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Quadrivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure North America Quadrivalent Flu Vaccine Sales Market Share by Countries in 2018
Table North America Quadrivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Quadrivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure North America Quadrivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure United States Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Europe Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Quadrivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure Europe Quadrivalent Flu Vaccine Sales Market Share by Company in 2018
Table Europe Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Europe Quadrivalent Flu Vaccine Sales Market Share by Type in 2018
Table Europe Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Europe Quadrivalent Flu Vaccine Sales Market Share by Application in 2018
Table Europe Quadrivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Europe Quadrivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Europe Quadrivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Quadrivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Europe Quadrivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure Germany Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Asia Pacific Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Quadrivalent Flu Vaccine Sales by Regions (2014-2019) (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Asia Pacific Quadrivalent Flu Vaccine Market Share by Type in 2018
Table Asia Pacific Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Asia Pacific Quadrivalent Flu Vaccine Market Share by Application in 2018
Table Asia Pacific Quadrivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Regions in 2018
Table Asia Pacific Quadrivalent Flu Vaccine Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share by Regions in 2018
Figure China Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Quadrivalent Flu Vaccine Sales by Company (2014-2019) (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Company (2014-2019)
Figure Central & South America Quadrivalent Flu Vaccine Sales Market Share by Company in 2018
Table Central & South America Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Central & South America Quadrivalent Flu Vaccine Market Share by Type in 2018
Table Central & South America Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Central & South America Quadrivalent Flu Vaccine Market Share by Application in 2018
Table Central & South America Quadrivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Central & South America Quadrivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Central & South America Quadrivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Quadrivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Central & South America Quadrivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure Brazil Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Type in 2018
Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Application in 2018
Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Countries in 2018
Table Middle East and Africa Quadrivalent Flu Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Quadrivalent Flu Vaccine Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Quadrivalent Flu Vaccine Revenue Market Share by Countries in 2018
Figure GCC Countries Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Egypt Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure South Africa Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Description and Business Overview
Table Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table Sanofi Pasteur Quadrivalent Flu Vaccine Sales Market Share in Global Market
Table Sanofi Pasteur Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table AstraZeneca Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table AstraZeneca Quadrivalent Flu Vaccine Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table CSL Company Details
Table CSL Description and Business Overview
Table CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table CSL Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table CSL Quadrivalent Flu Vaccine Sales Market Share in Global Market
Table CSL Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table Abbott Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table Abbott Quadrivalent Flu Vaccine Sales Market Share in Global Market
Table Abbott Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Quadrivalent Flu Vaccine Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Figure Quadrivalent Flu Vaccine Value Chain
Table Quadrivalent Flu Vaccine Distributors List
Table Quadrivalent Flu Vaccine Customers List
Table Global Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses) & (Million US$)
Figure Global Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Revenue Forecast 2019-2025 (Million US$)
Table Global Quadrivalent Flu Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Forecast by Type 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Type 2019-2025
Table Global Quadrivalent Flu Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Forecast by Application 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Application 2019-2025
Table Global Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Figure Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table North America Quadrivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table North America Quadrivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table North America Quadrivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Quadrivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure United States Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Canada Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Mexico Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table Europe Quadrivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Europe Quadrivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Quadrivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure France Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure UK Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Italy Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Russia Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure China Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Japan Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure South Korea Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure India Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Australia Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Indonesia Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Thailand Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Malaysia Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Philippines Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Vietnam Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Forecast by Countries 2019-2025 (K Doses)
Table Central & South America Quadrivalent Flu Vaccine Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Quadrivalent Flu Vaccine Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Quadrivalent Flu Vaccine Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Quadrivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure GCC Countries Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure Egypt Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Figure South Africa Quadrivalent Flu Vaccine Sales Forecast 2019-2025 (K Doses)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の三価インフルエンザワクチン産業調査2019-2025
    Global Trivalent Flu Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV17404 2019年11月18日 112Pages
    ※本調査レポートでは、世界の三価インフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。三価インフルエンザワクチンの種類別には、筋肉内注射、点鼻薬、皮内注射に、用途別には、病院、クリニック、公衆衛生...
  • 世界の魚ワクチン産業調査2019-2025
    Global Fish Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV15877 2019年11月16日 115Pages
    ※本調査レポートでは、世界の魚ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。魚ワクチンの種類別には、不活化魚ワクチン、弱毒魚ワクチン、トキソイド魚ワクチン、複合魚ワクチン、その他に、用途別には、獣医薬局...
  • 世界の遺伝子ワクチン産業調査2019-2025
    Global Genetic Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV15993 2019年11月16日 112Pages
    ※本調査レポートでは、世界の遺伝子ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。遺伝子ワクチンの種類別には、組換えタンパク質ワクチン、遺伝子ベースワクチンに、用途別には、人間、動物に、地域別には、北米、...
  • 世界の動物用生物学的ワクチン産業調査2019-2025
    Global Animal Biological Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV15107 2019年11月16日 144Pages
    ※本調査レポートでは、世界の動物用生物学的ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。動物用生物学的ワクチンの種類別には、経口、皮下、筋肉内、その他に、用途別には、ブタ、家禽、家畜、愛玩動物、養殖に、...
  • 世界の組換えタンパク質ワクチン産業調査2019-2025
    Global Recombinant Protein Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV16912 2019年11月18日 118Pages
    ※本調査レポートでは、世界の組換えタンパク質ワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。組換えタンパク質ワクチンの種類別には、細菌細胞培養、哺乳類細胞培養に、用途別には、人間、動物に、地域別には、北米...
  • 世界の鼻スプレーイ型ンフルエンザワクチン産業調査2019-2025
    Global Nasal Spray Flu Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
    QYR9NV16539 2019年11月18日 112Pages
    ※本調査レポートでは、世界の鼻スプレーイ型ンフルエンザワクチン市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。鼻スプレーイ型ンフルエンザワクチンの種類別には、三価インフルエンザワクチン、四価インフルエンザワクチに...
  • 7価肺炎球菌ワクチンのグローバル市場調査 2019年
    Global 7-Valent Pneumococcal Vaccine Market Professional Survey Report 2019
    QYR9NV15022 2019年11月16日 109Pages
    ※本調査レポートは、7価肺炎球菌ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、単回投与バイアル、充填済みシリンジに、用途別には、病院、クリニックにセ...
  • 10価肺炎球菌多糖ワクチンのグローバル市場調査 2019年
    Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Professional Survey Report 2019
    QYR9NV14876 2019年11月16日 104Pages
    ※本調査レポートは、10価肺炎球菌多糖ワクチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、単回投与バイアル、充填済みシリンジに、用途別には、病院、クリニッ...
  • 世界の三価インフルエンザワクチン産業調査2019-2025世界の三価インフルエンザワクチン産業調査2019-2025 In 2018, the global Trivalent Flu Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Trivalent Flu Vaccin…
  • 世界の鼻スプレーイ型ンフルエンザワクチン産業調査2019-2025世界の鼻スプレーイ型ンフルエンザワクチン産業調査2019-2025 In 2018, the global Nasal Spray Flu Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nasal Spray Flu V…
  • 世界の予防用ワクチン産業調査2019-2025世界の予防用ワクチン産業調査2019-2025 Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.In 2018, the global Preventive Vaccines market size was xx million US$ a…
  • 世界の魚ワクチン産業調査2019-2025世界の魚ワクチン産業調査2019-2025 Vaccination plays a vital role in large scale fish farming production. Vaccination of fish provides protection against common viral or bacterial diseases. Fish vaccines can radially reduce the mortality rate and increase the production rate. Fish vaccines is the best method to enhance the survival r…
  • 世界の動物用生物学的ワクチン産業調査2019-2025世界の動物用生物学的ワクチン産業調査2019-2025 In 2018, the global Animal Biological Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Animal Biologica…